| Q54417219 | An analysis of radiation necrosis of the central nervous system treated with bevacizumab. |
| Q40705444 | Anti-angiogenic therapy in high-grade glioma (treatment and toxicity). |
| Q37845201 | Bevacizumab as a treatment option for radiation-induced cerebral necrosis. |
| Q90498450 | Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis |
| Q38266418 | Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas |
| Q36300245 | Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature |
| Q33416917 | Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort |
| Q57266579 | Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2 |
| Q48761471 | Dehiscence of corticosteroid-induced abdominal striae in a 14-year-old boy treated with bevacizumab for recurrent glioblastoma |
| Q38606250 | Delayed brain radiation necrosis: pathological review and new molecular targets for treatment |
| Q30616602 | Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors |
| Q36731879 | Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors |
| Q85069922 | Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis |
| Q38641298 | First follow-up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases |
| Q55511946 | Gamma Knife treatment of malignant infantile brain tumors — Case report. |
| Q82621109 | Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients |
| Q46569297 | Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma |
| Q35885469 | Laser interstitial thermal therapy in the management of brain metastasis and radiation necrosis after radiosurgery: An overview |
| Q37826655 | Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience |
| Q41869382 | Low-dose bevacizumab is effective in radiation-induced necrosis |
| Q37819809 | Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier |
| Q36486272 | Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. |
| Q33685551 | Novel drugs in pediatric gliomas |
| Q30454883 | Opportunities and challenges for successful use of bevacizumab in pediatrics |
| Q30418915 | Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? |
| Q41109977 | Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma |
| Q35421487 | Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma |
| Q88874019 | Pseudoprogression successfully treated with bevacizumab in a child with spinal pilocytic astrocytoma |
| Q48731416 | Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia |
| Q26749591 | State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature |
| Q30451641 | Stereotactic radiosurgery for WHO grade I meningiomas |
| Q35049632 | Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes. |
| Q38903221 | Treatment of pediatric cerebral radiation necrosis: a systematic review |
| Q90392919 | Treatment of radiation-induced myelopathy with bevacizumab |
| Q37708428 | Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience |
| Q47955352 | Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy |